News
Positron Emission Tomography Market to grow at 5% CAGR driven by oncology and neurology uses by 2030
The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in ...
Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s ...
Are men’s and women’s hearts that different? Yes, they are, and knowing those differences could save a woman’s life.
22h
Paulick Report on MSNReview: What Diagnostics Are Available For Equine Lameness?The most common lameness issues vary by equine disciplines and breed. McCarrel notes that her experience may be slightly ...
Researchers at Sylvester Comprehensive Cancer Center reveal how body composition analysis predicts treatment response in ...
The Alzheimer's Association international conference highlighted the roles exercise, lead exposure, blood tests and food ...
With faster scanning capabilities, the new machine allows the health center to serve more patients in need of cancer screening.
A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.
2d
HealthDay on MSNIntranasal Administration of PET Radiotracer Delivers Insulin to Multiple Brain RegionsIntranasal administration of [68Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a ...
The Food and Drug Administration has granted Fast Track designation to PMN310 for the treatment of Alzheimer disease.
Mayo Clinic Jacksonville supports a blood test for to diagnose Alzheimer's while Baptist Health implanted its first atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results